CRISPR Therapy Exceeds Targets in Thalassemia, Sickle Cell Disease
Data from two pivotal trials suggest that a single infusion of the CRISPR-based…
Browsing Tag
Thalassemia
Thalassemia: 50 per cent patients are insured, says Apollo – ET HealthWorld
Chennai: Apollo Cancer Centre, among the first private hospitals in the state to collaborate with the government for performing bone marrow…
Thalassemia inst to come up at RUHS Hosp – ET HealthWorld
Jaipur: For better management of thalassemia, sickle cell disease and hemophilia, the State Institute of Hemoglobinopathy Management,…
Indraprastha Apollo Hospitals, New Delhi organises thalassemia awareness programme…
New Delhi: Indraprastha Apollo Hospitals, New Delhi organised an awareness event around the rising case of thalassemia patients across…
Beta Thalassemia Clinical Trials Pipeline Analysis: 22+ Companies are Working to…
New York, USA, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Beta Thalassemia Clinical Trials Pipeline Analysis: 22+ Companies are Working to Improve the Treatment Space | DelveInsight The…
Thalassemia- A Disability That can be Treated With a Stem Cell Transplant
Thalassemia is a blood condition caused by a genetic defect in hemoglobin. It lowers the blood's ability to transport oxygen in the body. In India, this illness affects more…
Propulsion of Thalassemia Pipeline as Novel and Extensive 25+ Therapies Likely to…
New York, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Propulsion of Thalassemia Pipeline as Novel and Extensive 25+ Therapies Likely to Enter in the Treatment Domain | DelveInsight DelveInsight’s…
Noida: Child PGI gets nod to expand treatment of rare ailments – ET HealthWorld
Noida: The Indian Council of Medical Research (ICMR) has approved Child PGI in Noida’s Sector 30 as a participating centre for the Union health ministry’s rare diseases registry programme,…
Global Hemoglobinopathies Market is Expected to Reach $7.0 Billion by 2031: Says AMR
Portland, OR, Aug. 25, 2022 (GLOBE NEWSWIRE) -- The Global Hemoglobinopathies Market size was estimated at $4.2 billion in 2021 and is expected to hit $7.0 billion by 2031, registering a…
PK Modulator Shows Promise in Thalassemia
In a small study, the allosteric pyruvate kinase (PK) modulator mitapivat (Pyrukynd) was…